Skip to main content

Table 1 Clinical characteristics of patients

From: Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified

 

UC

CD

IBD-U

PSC-UC

AIP-UC

Control

N

24

15

10

4

3

9

Sex

      

Male/female

11/13

10/5

7/3

4/0

2/1

8/1

Age

41.0 (26.7–55.3)

33.0 (27.0–39.0)

36.5 (30.4–42.6)

33.5 (24.8–42.2)

49.0 (35.0–63.0)

68.0 (62.3–70.7)

Duration [years]

7.5 (3.2–11.8)

1.0 (0–3.5)

4.5 (0–9.0)

8.0 (1.1–14.9)

6.0 (2.5–8.5)

 

Disease types

      

Proctitis

6 (25.0%)

  

2 (50.0%)

2 (66.7%)

 

Left-sided colitis

7 (29.2%)

  

0 (0%)

1 (33.3%)

 

Right-sided colitis

0 (0%)

  

2 (50.0%)

0 (0%)

 

Pancolitis

11 (45.8%)

     

Ileitis

 

4 (26.7%)

    

Ileocolitis

 

7 (46.7%)

4 (40%)

   

Colitis

 

4 (26.7%)

6 (60%)

   

Part of biopsy

      

[R/S/D/T/A/I]

14/7/2/1/0/0

1/2/1/2/4/5

2/1/1/0/3/3

1/1/0/0/2/0

2/1/0/0/0/0

6/1/0/0/2/0

Endoscopic index

      

REI

6.5 (5.0–8.0)

  

5.0 (3.6–6.4)

5.0 (2.5–7.5)

 

SES-CD

 

10.0 (7.5–12.5)

    

Treatment

      

None

1

2

3

0

1

9

5-ASA

20

7

7

4

2

0

Corticosteroid

5

1

1

2

1

0

Thiopurine

1

0

1

0

1

0

Tacrolimus

1

0

0

0

0

0

Anti-TNFα

3

6

4

0

0

0

  1. Median (interquartile range)
  2. R rectum, S sigmoid colon, D descending colon, T transverse colon, A ascending colon, I ileum, REI Rachmilewitz endoscopic index, SES-CD simple endoscopic activity score for Crohn's disease